globe
Acland (no date) Acland’s Atlas of Human Anatomy. Available at: http://www.salford.ac.uk/library/access-to-e-resources/library-databases/aclands-video-atlas-of-human-anatomy.
Ali, T. et al. (2009) ‘Osteoporosis in Inflammatory Bowel Disease’, The American Journal of Medicine, 122(7), pp. 599–604. doi: 10.1016/j.amjmed.2009.01.022.
Bayless, T. M. and Hanauer, S. B. (2011) Advanced therapy of inflammatory bowel disease. 3rd ed. Shelton, Conn: People’s Medical Publishing House. Available at: http://ebookcentral.proquest.com/lib/salford/detail.action?docID=3386948.
Best, W. R. et al. (1976) ‘Development of a Crohn’s Disease Activity Index’, Gastroenterology. Available at: https://www.gastrojournal.org/article/S0016-5085(76)80163-1/pdf.
De Bie, C. et al. (2015) ‘Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease’, Alimentary Pharmacology & Therapeutics, 42(11-12), pp. 1294–1302. doi: 10.1111/apt.13423.
British National Formulary: 72: September 2016 - March 2017 (2016). London: BMJ Group : Pharmaceutical Press.
British Society of Gastroenterology (2006) ‘Patient information leaflet. British Society of Gastroenterology. AZATHIOPRINE / 6 MERCAPTOPURINE’, Budesonide for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009 Jan 21, 21(1). Available at: http://www.bsg.org.uk/pdf_word_docs/aza_ibd_dr.doc.
British Society of Gastroenterology (no date a) Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Available at: http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/ccs_10.pdf.
British Society of Gastroenterology (no date b) Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease. Available at: http://www.bsg.org.uk/pdf_word_docs/ost_coe_ibd.pdf.
Bulman, C. and Schutz, S. (2013) Reflective practice in nursing. 5th ed. Oxford: Wiley-Blackwell. Available at: https://salford.idm.oclc.org/login?&url=http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9781118307762.
Canham, P. (2010) ‘IBD patient panels: a personal reflection on three stages of development of an IBD Patient Involvement Project, initiated and supported by Crohn’s and Colitis UK’, Frontline Gastroenterology. doi: 10.1136/fg.2009.000349.
Capsule Endoscopy Considered Best Tool for Detecting Crohn’s in Small Bowel (no date). doi: https://www.gastroendonews.com/In-the-News/Article/09-18/Capsule-Endoscopy-Considered-Best-Tool-for-.
Carter, M. J., Lobo, A. J. and Travis, S. P. L. (2004) ‘Guidelines for the management of inflammatory bowel disease in adults’, Gut. London: BMJ Pub. Group, 53(Suppl V), p. v.1–v.16.
‘Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences’ (2004) Gastroenterology, 126 (6). doi: 10.1053/j.gastro.2004.01.063.
Connelly, T. M. (2014) ‘Predictors of recurrence of Crohn’s disease after ileocolectomy: A review’, World Journal of Gastroenterology, 20(39). doi: 10.3748/wjg.v20.i39.14393.
Critically Appraising Evidence for Healthcare (no date). Available at: http://ovidsp.tx.ovid.com/sp-3.22.1b/ovidweb.cgi?QS2=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.
Crohn’s and Colitis UK (no date) Strategy Plan 2013. Available at: http://www.crohnsandcolitis.org.uk/.
‘Crohn’s disease: management | Guidance and guidelines | NICE’ (no date). NICE. Available at: https://www.nice.org.uk/guidance/CG152.
Cronenwett, J. L. and Johnston, K. W. (eds) (2014) Rutherford’s vascular surgery. Eighth edition. Philadelphia, PA: Elsevier Saunders. Available at: https://salford.idm.oclc.org/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&site=ehost-live&custid=s2888710&AN=974415.
Fernando Gomollón Axel Dignass Vito Annese Herbert Tilg Gert Van Assche James O. Lindsay Laurent Peyrin-Biroulet Garret J. Cullen Marco Daperno Torsten Kucharzik Florian Rieder Sven Almer Alessandro Armuzzi Marcus Harbord Jost Langhorst Miquel Sans Yehuda Chowers Gionata Fiorino Pascal Juillerat Gerassimos J. Mantzaris Fernando Rizzello Stephan Vavricka Paolo Gionchetti (no date) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. Available at: https://academic.oup.com/ecco-jcc/article/11/1/3/2456546/3rd-European-Evidence-based-Consensus-on-the.
Fernando Magro Paolo Gionchetti Rami Eliakim Sandro Ardizzone Alessandro Armuzzi Manuel Barreiro-de Acosta Johan Burisch Krisztina B. Gecse Ailsa L. Hart Pieter Hindryckx Cord Langner Jimmy K. Limdi Gianluca Pellino Edyta Zagórowicz Tim Raine Marcus Harbord Florian Rieder (no date) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Available at: https://academic.oup.com/ecco-jcc/article/2966917/Third.
Fotis Barkas, Evangelos Liberopoulos, Anastazia Kei, and Moses Elisaf (2013) ‘Electrolyte and acid-base disorders in inflammatory bowel disease’, Annals of gastroenterology: quarterly publication of the Hellenic Society of Gastroenterology. Athens, Greece: Hellenic Society of Gastroenterology, 26(1), pp. 23–28.
Gasche, C. (2004) ‘Iron, anaemia, and inflammatory bowel diseases’, Gut, 53(8), pp. 1190–1197. doi: 10.1136/gut.2003.035758.
Gert Van Assche, Axel Dignass, Julian Panes, Laurent Beaugerie, John Karagiannis, Mathieu Allez, Thomas Ochsenkühn, Tim Orchard, Gerhard Rogler, Edouard Louis, Limas Kupcinskas, Gerassimos Mantzaris, Simon Travis, Eduard Stange for the European Crohn’s and Colitis Organisation (ECCO) (2010) ‘The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis’, Journal of Crohn’s and Colitis. Elsevier, 4, pp. 7–27. Available at: https://www.ecco-ibd.eu/images/6_Publication/6_3_ECCO%20Guidelines/2010_CD_guidelines_definitions_diagnosis.pdf.
Griffiths, M. (2015) Gastrointestinal system. 4th edition - updated. Edinburgh: Mosby. Available at: http://ebookcentral.proquest.com/lib/salford/detail.action?docID=3563728.
H. Lochs, S.P. Allison, R. Meier, M. Pirlicha, J. Kondrup, St. Schneider, G. van den Berghe, C. Pichard (2006) ‘Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, Definitions and General Topics’, Clinical Nutrition. London : Harcourt Publishers, 25(2), pp. 180–186.
Hall, V. (2014) ‘Understanding the causes and symptoms of IBD’, Nursing Times. London: EMAP Communications. Available at: https://contentstore.cla.co.uk/secure/link?id=df4b0b51-7ac0-e611-80c7-005056af4099.
Hanauer, S. B. (2006) ‘Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities’, Inflammatory Bowel Diseases, 12, pp. S3–S9. doi: 10.1097/01.MIB.0000195385.19268.68.
Harvey, R.F. and Bradshaw, J.M. (1980) ‘A Simple Index of Crohns Disease’, The Lancet. Elsevier Science, 315(8167). Available at: https://www.sciencedirect.com/science/article/pii/S0140673680927671.
Hernández-Sampelayo, P. et al. (2010) ‘Contribution of nurses to the quality of care in management of inflammatory bowel disease: A synthesis of the evidence’, Journal of Crohn’s and Colitis, 4(6), pp. 611–622. doi: 10.1016/j.crohns.2010.08.009.
IBD Standards Group (no date) Quality Care: Service Standards for the healthcare of people who have Inflammatory Bowel Disease (IBD). Available at: http://www.ibdstandards.org.uk/uploaded_files/IBDstandards.pdf.
‘IBDstandards.pdf’ (no date). Available at: http://www.ibdstandards.org.uk/uploaded_files/IBDstandards.pdf.
‘Inflammatory Bowel Disease.pdf’ (no date). Available at: http://www.colonoscopy.ru/books/rar/Inflammatory%20Bowel%20Disease.pdf.
Infliximab (review) and adalimumab for the treatment of Crohn’s disease | Guidance and guidelines | NICE (no date). NICE. Available at: http://www.nice.org.uk/guidance/ta187.
Irving, P. M. et al. (2011) Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges. 2nd ed. Hoboken: Wiley. Available at: https://salford.idm.oclc.org/login?&url=http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9781444342543.
Jakobovits, S. L. and Travis, S. P. L. (2006) ‘Management of acute severe colitis’, British Medical Bulletin, 75-76(1), pp. 131–144.
Janneke van der Woude, C.J., Kolacek, S., Dotan, I., Oresland, T., Vermeire, S., Munkholm, P., Mahadevan, U., Mackillop, L. and Dignass, A (no date) European evidence-based consensus on reproduction in inflammatory bowel disease. Available at: http://www.planapregnancy.co.uk/PP2010/static/ibd_euro_guidelines.pdf.
Jobanputra, S. and Weiss, E. (2007) ‘Strictureplasty’, Clinics in Colon and Rectal Surgery, 20(4), pp. 294–302.
Kalla, R. et al. (2018) ‘Patients’ perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey’, Scandinavian Journal of Gastroenterology. Available at: https://contentstore.cla.co.uk/secure/link?id=58caf515-0d02-e911-80cd-005056af4099.
Kumar, P. J. and Clark, M. L. (eds) (2017) Kumar & Clark’s clinical medicine. 9th edition. Edinburgh: Elsevier. Available at: https://salford.idm.oclc.org/login?&url=http://ebookcentral.proquest.com/lib/salford/detail.action?docID=4676140.
Kurtz, S. M. and Silverman, J. D. (1996) ‘The Calgary-Cambridge Referenced Observation Guides: an aid to defining the curriculum and organizing the teaching in communication training programmes’, Medical Education, 30(2), pp. 83–89. doi: 10.1111/j.1365-2923.1996.tb00724.x.
Lewis, J. D., Schwartz, J. S. and Lichtenstein, G. R. (2000) ‘Azathioprine for maintenance of remission in Crohn’s disease: Benefits outweigh the risk of lymphoma’, Gastroenterology, 118(6), pp. 1018–1024.
Livia Biancone, Pierre Michetti, Simon Travis, Johanna C. Escher, Gabriele Moser, Alastair Forbes, Jörg C Hoffmann, Axel Dignass, Paolo Gionchetti, Günter Jantschek, Ralf Kiesslich, Sanja Kolacek, Rod Mitchell, Julian Panes, Johan Soderholm, Boris Vucelic, Eduard Stange, for the European Crohn’s and Colitis Organisation (ECCO) (2008) ‘Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis’, Journal of Crohn’s and Colitis. Journal of Crohn’s and Colitis, 2, pp. 63–92.
Lochs, H. (2010a) ‘Basics in Clinical Nutrition: Nutritional support in inflammatory bowel disease’, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 5(2), pp. e100–e103.
Lochs, H. (2010b) ‘Basics in Clinical Nutrition: Nutritional support in inflammatory bowel disease’, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 5(2), pp. e100–e103. doi: 10.1016/j.eclnm.2009.06.009.
Di Mambro, A. J., Terlevich, A. and Probert, C. (2007) ‘Non-Invasive Diagnosis and Assessment’, in Clinical Dilemmas in Inflammatory Bowel Disease. Blackwell, pp. 8–10. Available at: https://ebookcentral-proquest-com.salford.idm.oclc.org/lib/salford/reader.action?docID=351012&ppg=24.
Managing Adult Malnutrition in the Community (no date). Available at: http://www.guidelines.co.uk/nutrition_bapen_rcgp_malnutrition_jun14#.Vm_Rd8nlbBs.
‘Managing Malnutrition’ (no date). Available at: http://malnutritionpathway.co.uk/downloads/Managing_Malnutrition.pdf.
McDonald, J. W. et al. (1996) ‘Methotrexate for induction of remission in refractory Crohn’s disease’, in Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD003459.pub4.
McDonald JW, Tsoulis DJ, MacDonald JK, Feagan BG. (no date) Methotrexate for treatment of active treatment resistant Crohn’s disease. Available at: http://summaries.cochrane.org/CD003459/methotrexate-for-treatment-of-active-treatment-resistant-crohns-disease.
Munkholm, P. et al. (2010) ‘Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine’, European Journal of Gastroenterology & Hepatology, 22(8), pp. 912–916. doi: 10.1097/MEG.0b013e32833944bf.
National Patient Safety Agency (no date) Improving compliance with oral methotrexate guidelines. Available at: http://www.nrls.npsa.nhs.uk/resources/?entryid45=59800.
Orchard, T. R. et al. (2011) Inflammatory Bowel Disease: an Atlas of Investigation and Management. Oxford: Clinical Pub. Available at: https://salford.idm.oclc.org/login?&url=http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9781846925061.
Patel, V. et al. (2014) ‘Methotrexate for maintenance of remission in Crohn’s disease’, The Cochrane database of systematic reviews., (8). doi: 10.1002/14651858.CD006884.pub3.
Prochaska JO, DiClemente CC (1983) ‘Stages and processes of self-change of smoking: toward an integrative model of change’, Journal of consulting and clinical psychology. Washington, DC: American Psychological Association, 51(3), pp. 390–395.
Proscaka & De Clemente (1983) (no date) ‘Microsoft Word - Stages of Change.doc - STEPUP_Stages_of_Change.pdf.’ Available at: http://www.stepupprogram.org/docs/handouts/STEPUP_Stages_of_Change.pdf.
Rampton, D. and Shanahan, F. (2014) Inflammatory bowel disease. Fourth edition. Abingdon: Health Press Limited. Available at: https://salford.idm.oclc.org/login?&url=http://lib.myilibrary.com/ProductDetail.aspx?id=909226.
Rezaie, A. et al. (1996a) ‘Budesonide for induction of remission in Crohn’s disease’, in Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000296.pub4.
Rezaie, A. et al. (1996b) ‘Budesonide for induction of remission in Crohn’s disease’, in Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000296.pub4.
Van Rheenen, P. F., Van de Vijver, E. and Fidler, V. (2010) ‘Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis’, BMJ, 341(jul15 1), pp. c3369–c3369.
Royal College of Nursing (no date) Role Descriptives for Inflammatory Bowel Disease Specialists. RCN Guidance. Available at: https://www.rcn.org.uk/professional-development/publications/pub-003194.
Rubin, G. P. et al. (2000) ‘Inflammatory bowel disease: epidemiology and management in an English general practice population’, Alimentary Pharmacology and Therapeutics, 14(12), pp. 1553–1559. doi: 10.1046/j.1365-2036.2000.00886.x.
Sandborn, W. J. et al. (2007) ‘Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial’, Gut, 56(9), pp. 1232–1239. doi: 10.1136/gut.2006.106781.
Schroeder, K. W., Tremaine, W. J. and Ilstrup, D. M. (1987) ‘Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis’, New England Journal of Medicine, 317(26), pp. 1625–1629. doi: 10.1056/NEJM198712243172603.
Seow CH, Benchimol EI, Steinhart AH, Griffiths AM, Otley AR. (2009) ‘Budesonide for Crohn’s disease’, Expert Opinion on Drug Metabolism & Toxicology. Taylor & Francis, 5(8), pp. 971–979. doi: 10.1517/17425250903124355.
Shea, B. et al. (1996a) ‘Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis’, in Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000951.pub2.
Shea, B. et al. (1996b) ‘Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis’, in Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000951.pub2.
Sidhu, P. S. et al. (2014) ‘Which 5-ASA? Understanding the choices in ulcerative colitis therapy’, Gastrointestinal Nursing, 12(5), pp. 17–26. doi: 10.12968/gasn.2014.12.5.17.
Sostegni, R. et al. (2003) ‘Crohn’s disease: monitoring disease activity’, Alimentary Pharmacology and Therapeutics, 17(s2), pp. 11–17. doi: 10.1046/j.1365-2036.17.s2.17.x.
Sostegni, R., Daperno, M., Scaglione, N., Lavagna, A., Rocca, R. and Pera, A. (2003) ‘Crohns disease: monitoring disease activity’, Alimentary pharmacology & therapeutics (Online). Oxford, England : Blackwell Science, 17(Suppl. 2), pp. 11–17.
Stange, E. F. (2006) ‘European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis’, Gut, 55(suppl_1), pp. i1–i15. doi: 10.1136/gut.2005.081950a.
Stein, S. H., Rood, R. P. and Crohn’s & Colitis Foundation of America (1999) Inflammatory bowel disease: a guide for patients and their families. 2nd ed. Philadelphia: Lippincott-Raven Publishers.
Stenner, J. et al. (2001) ‘Audit of the management of severe ulcerative colitis in a DGH’, Gut, 48(Supplement 1), pp. 87–88.
Targan, S. R., Shanahan, F. and Karp, L. C. (2010) Inflammatory Bowel Disease: Translating Basic Science into Clinical Practice. Hoboken: Wiley. Available at: http://eu.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=4429316180001611&institutionId=1611&customerId=1600.
‘The impact of smoking in Crohn’s disease: no smoke without fire’ (2010) Frontline Gastroenterology. BMJ Publishing Group Ltd & British Society of Gastroenterology, 1(3), pp. 156–164. doi: 10.1136/fg.2010.001487.
‘The Management of Anal Fissure: ACPGBI Position Statement’ (2008) Colorectal Disease Position Statements. Wiley-Blackwell, 10(10s3). doi: 10.1111/j.1463-1318.2008.01681.x.
Truelove, S. C. and Witts, L. J. (1955) ‘Cortisone in Ulcerative Colitis’, BMJ, 2(4947), pp. 1041–1048. doi: 10.1136/bmj.2.4947.1041.
‘Ulcerative colitis: management | Guidance and guidelines | NICE’ (no date). NICE. Available at: https://www.nice.org.uk/guidance/CG166.
Visible Body (no date). Available at: http://www.salford.ac.uk/library/access-to-e-resources/library-databases/visible-body/_nocache.
W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch (2010) ‘A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease’, Journal of Crohn’s and Colitis. Elsevier Inc, 4, pp. 221–256. doi: doi:10.1016/j.crohns.2009.12.001.
Welcome to Visible Body (no date a). Available at: http://ovid.visiblebody.com/?osptok=7830b18b97e7f2fb3992022c117a0a8007b71005345077fbec5774025c9e2cb29aee82a38e6c1f444e9d3fe38e01a0571c7294b939813d90771151ee8527d74e1d192a720aa484eb85e1ad636f29069713ed9cb91da8e566d75b008e94eb3b82eee4a7f84fb7a4edee8165e7f9ff76d2352e4662d9fe12fae3b89e9103f0f300bbe03c25bdeda16b826ea0a26e6f4a75bab84cba93ae4cba7d12b1b871e73aaba1ddb4aa4e467156e9d2237403a1f64d410111efb48753a43300aa58af6e68441cacb1e36dee4206ba212ea90f84545bbed2596177230b05f323b5840816e784e7126c4d754c84b954cdf42e4de871c8.
Welcome to Visible Body (no date b). Available at: http://www.salford.ac.uk/library/access-to-e-resources/library-databases/visible-body/_nocache.
Whayman, K. (2011) ‘Chapter 19: Supporting and Educating Patients’, in Inflammatory bowel disease nursing. London: Quay, pp. 333–358.
Whayman, K. et al. (2012) ‘Developing the role of the clinical nurse specialist in inflammatory bowel disease’, Gastrointestinal Nursing, 10(8), pp. 22–27. doi: 10.12968/gasn.2012.10.8.22.
Whayman, K., Duncan, J. and O’Connor, M. (2011) ‘Supporting and Educating Patients’, Inflammatory bowel disease nursing. London: Quay. Available at: https://contentstore.cla.co.uk/secure/link?id=f9b7191f-83e1-e611-80c9-005056af4099.
Xavier, R. J. and Podolsky, D. K. (2007) ‘Unravelling the pathogenesis of inflammatory bowel disease’, Nature, 448(7152), pp. 427–434.